TY  - JOUR
AU  - Gubern-Mérida, Carme
AU  - Comajoan, Pau
AU  - Huguet, Gemma
AU  - García-Yebenes, Isaac
AU  - Lizasoain, Ignacio
AU  - Moro, María Ángeles
AU  - Puig-Parnau, Irene
AU  - Sánchez, Juan Manuel
AU  - Serena, Joaquín
AU  - Kádár, Elisabet
AU  - Castellanos, Mar
PY  - 2022
DO  - 10.1007/s12035-021-02644-y
UR  - http://hdl.handle.net/20.500.12105/15659
AB  - Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for acute ischemic stroke. However, its administration is still limited due to the associated increased risk of hemorrhagic...
LA  - eng
PB  - Humana Press
KW  - Brain Ischemia
KW  - Ischemic Stroke
KW  - Stroke
KW  - Animals
KW  - Brain
KW  - Caveolin 1
KW  - Endothelial Cells
KW  - Hemorrhage
KW  - Infarction, Middle Cerebral Artery
KW  - Mice
KW  - Tissue Plasminogen Activator
TI  - Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration.
TY  - journal article
ER  -